Doxycycline+Tylosin Powder enyibilikayo
.png)
.png)
.png)
.png)
Isenzo se-Pharmacological
I-Pharmacodynamics iTylosin sisilwanyane esikhethekileyo se-macrolide antibiotic enefuthe elinamandla kwi-mycoplasma.I-antibacterial spectrum iyafana ne-erythromycin, kwaye iibhaktheriya ezibuthathaka ze-Gram yi-Staphylococcus aureus (kubandakanywa ne-penicillin-resistant Staphylococcus aureus), i-pneumococcus, i-streptococcus, i-Bacillus anthracis, i-Erysipelothrix, i-Porthusipelothrix, i-Porthusipelothrix, i-Porthusipelothrix , i-Porthusiopathrix , i-Porthusipelothrix , i-Emrhusipelothrix, i-Porthusipelothrix , i-Emrhusipelothrix , i-Porthusipelothrix, i-Emrusipelothrix, i-Porthusipelothrix, i-Prhusipelothrix, i-Prhusipelothrix, i-Prhusipelothrix, i-Emrhusipelothrix, i-Emrhusipelothrix, kunye ne-Emerusipelothrix.Iibhaktheriya ezibuthathaka kwigram-negative ziquka i-Haemophilus, i-meningococcus kunye ne-Pasteurella.Iibhaktheriya ezithintekayo zinokuhlakulela ukuxhathisa le mveliso, kwaye i-Staphylococcus aureus inokuchasana okunqamlezayo kule mveliso kunye ne-erythromycin.
Pharmacokinetics
I-Tylosin inokuthi ifakwe kwi-gastrointestinal tract emva kokulawulwa komlomo, kwaye i-peak concentrations ifike kwi-1 iyure emva kokulawulwa komlomo kwiingulube, ngelixa i-tylosin phosphate iyancipha.I-Tylosin isasazwa ngokubanzi emzimbeni emva kokuxutywa, kwaye i-concentration ye-organ emva kwe-injection yi-2 kumaxesha e-3 aphezulu kunokuba emva kokulawulwa komlomo, kodwa akulula ukungena kwi-cerebrospinal fluid.
Ukusebenzisana kweziyobisi
(1) Akufanele isetyenziswe ngexesha elifanayo kuba inenjongo efanayo nezinye i-macrolides, i-lincosamines kunye ne-amide alcohols.
(2), indibaniselwano kunye ne-β-lactam ibonise ukuchasana.
I-Hebei Veyong Pharmaceutical Co., Ltd, yasekwa kwi-2002, ehlala kwisiXeko saseShijiazhuang, kwiPhondo laseHebei, eChina, ecaleni kwe-Capital Beijing.Ulishishini elikhulu leyeza lezilwanyana eliqinisekisiweyo le-GMP, eline-R&D, imveliso kunye nokuthengiswa kwee-APIs zonyango lwezilwanyana, amalungiselelo, ukutya okuxutywe kwangaphambili kunye nezongezo zokutya.NjengeZiko lobuGcisa lePhondo, iVeyong iye yaseka inkqubo yeR&D ehlaziyiweyo yeyeza elitsha lezilwanyana, kwaye lishishini elaziwa kuzwelonke leteknoloji esekelwe kunyango lwezilwanyana, kukho iingcali zobugcisa ezingama-65.I-Veyong ineziseko ezimbini zokuvelisa: i-Shijiazhuang kunye ne-Ordos, apho isiseko se-Shijiazhuang sihlanganisa indawo ye-78,706 m2, kunye neemveliso ze-API ze-13 ezibandakanya i-Ivermectin, i-Eprinomectin, i-Tiamulin Fumarate, i-Oxytetracycline hydrochloride ects, kunye ne-11, i-injection oral solutions, i-injection oral solutions. , i-premix, i-bolus, i-pesticides kunye ne-disinfectant, njl.IVeyong ibonelela ngee-APIs, ngaphezulu kwe-100 yamalungiselelo eleyibhile, kunye nenkonzo ye-OEM & ODM.
I-Veyong ibona ukubaluleka okukhulu kulawulo lwenkqubo ye-EHS(Environment, Health & Safety), kwaye ifumene i-ISO14001 kunye nezatifikethi ze-OHSAS18001.I-Veyong idweliswe kumashishini amashishini asakhasayo anobuchule kwiPhondo laseHebei kwaye inokuqinisekisa ukubonelela ngokuqhubekayo kweemveliso.
I-Veyong yaseka inkqubo epheleleyo yolawulo lomgangatho, yafumana isatifikethi se-ISO9001, isatifikethi se-GMP sase-China, isiqinisekiso se-APVMA se-GMP sase-Australia, isatifikethi se-GMP sase-Ethiopia, isatifikethi se-Ivermectin CEP, kwaye siphumelele ukuhlolwa kwe-US FDA.I-Veyong ineqela lobuchwephesha lobhaliso, intengiso kunye nenkonzo yobugcisa, inkampani yethu ifumene ukuthembela kunye nenkxaso kubathengi abaninzi ngomgangatho wemveliso ogqwesileyo, umgangatho ophezulu wokuthengisa kwangaphambili kunye nenkonzo yasemva kokuthengisa, ulawulo olunzulu kunye nolwenzululwazi.I-Veyong yenze intsebenziswano yexesha elide kunye namashishini amaninzi amachiza ezilwanyana awaziwayo ngamazwe ngamazwe kunye neemveliso ezithunyelwa eYurophu, eMzantsi Melika, kuMbindi Mpuma, e-Afrika, e-Asia, njl. ngaphezu kwamazwe angama-60 kunye nemimandla.
